Elite Pharmaceuticals's total assets for Q2 2026 were $117.25M, an increase of 5.31% from the previous quarter. ELTP total liabilities were $44.99M for the fiscal quarter, a -29.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.